News

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but their uptake remained limited, with only 3% of eligible patients ...
inauthentic semaglutide drugs." Two weeks ago, Lilly sued an Indianapolis spa, Premier Weight Loss, claiming that it buys autoinjector pens filled with tirzepatide, cracks them open, breaking a ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
How Does Semaglutide Work for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic. Wegovy. Rybelsus. What do these medications have in common? They all contain ...
systems in the U.S. Only 2.3% of over 39 million eligible adults received prescriptions for semaglutide or tirzepatide (Mounjaro, Zepbound) for obesity between 2021 and 2024. (JAMA) Eli Lilly is ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...